Jonsson Comprehensive Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Employees: -

Market Cap: -

Website: http://www.cancer.ucla.edu

Clinical Trials

CCI-779 in Treating Patients With Prostate Cancer

Phase 2

Completed

Conditions: Prostate Cancer

First Posted Date: 2004-03-26

Last Posted Date: 2013-06-24

Lead Sponsor: Jonsson Comprehensive Cancer Center

Registration Number: NCT00012142

Locations: 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States

Monoclonal Antibody in Treating Patients With Acute Myelogenous Leukemia

Phase 2

Conditions: Leukemia

First Posted Date: 2004-03-25

Last Posted Date: 2013-12-19

Lead Sponsor: Jonsson Comprehensive Cancer Center

Registration Number: NCT00006084

Locations: 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States

Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Phase 1

Conditions: Prostate Cancer

First Posted Date: 2004-03-24

Last Posted Date: 2013-08-07

Lead Sponsor: Jonsson Comprehensive Cancer Center

Registration Number: NCT00005992

Locations: 🇺🇸
University of Texas - MD Anderson Cancer Center, Houston, Texas, United States
🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States

Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia

Phase 3

Conditions: Fever, Sweats, and Hot Flashes
Infection
Leukemia
Lymphoma
Neutropenia
Unspecified Adult Solid Tumor, Protocol Specific

First Posted Date: 2004-03-17

Last Posted Date: 2013-12-19

Lead Sponsor: Jonsson Comprehensive Cancer Center

Registration Number: NCT00020865

Locations: 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States

Cetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck That Has Not Responded to Cisplatin Chemotherapy

Phase 2

Completed

Conditions: Head and Neck Cancer

First Posted Date: 2004-03-16

Last Posted Date: 2009-03-09

Lead Sponsor: Jonsson Comprehensive Cancer Center

Registration Number: NCT00004865

Locations: 🇺🇸
Kimball Medical Center, Lakewood, New Jersey, United States
🇺🇸
Monmouth Medical Center, Long Branch, New Jersey, United States
🇺🇸
Cooper Cancer Institute, Camden, New Jersey, United States

Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Not Applicable

Completed

Conditions: Cancer

First Posted Date: 2004-03-10

Last Posted Date: 2020-08-03

Lead Sponsor: Jonsson Comprehensive Cancer Center

Registration Number: NCT00079222

Locations: 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States

Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Hematologic Cancer

Phase 1

Withdrawn

Conditions: Leukemia
Myelodysplastic Syndromes
Lymphoma

First Posted Date: 2004-02-16

Last Posted Date: 2020-07-31

Lead Sponsor: Jonsson Comprehensive Cancer Center

Registration Number: NCT00004114

Rituximab in Treating Patients With Waldenstrom's Macroglobulinemia

Phase 2

Completed

Conditions: Lymphoma

Interventions: Biological: rituximab

First Posted Date: 2004-02-12

Last Posted Date: 2020-08-03

Lead Sponsor: Jonsson Comprehensive Cancer Center

Target Recruit Count: 8

Registration Number: NCT00004889

Locations: 🇺🇸
Walter Reed Army Medical Center, Washington, District of Columbia, United States
🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States

and more 5 locations

Radiation Therapy Following Surgery to Remove Brain Metastases

Not Applicable

Completed

Conditions: Metastatic Cancer

First Posted Date: 2004-02-06

Last Posted Date: 2020-08-03

Lead Sponsor: Jonsson Comprehensive Cancer Center

Target Recruit Count: 20

Registration Number: NCT00003320

Locations: 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States

Squalamine Lactate Plus Carboplatin in Treating Patients With Recurrent or Refractory Stage III or Stage IV Ovarian Cancer

Phase 2

Conditions: Ovarian Cancer

First Posted Date: 2004-02-04

Last Posted Date: 2013-12-18

Lead Sponsor: Jonsson Comprehensive Cancer Center

Registration Number: NCT00021385

Locations: 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy